Background: The association between toxoplasmosis and psychiatric disorders has been reported in a few anecdotal reports.
Background
There have been only a few case reports associating toxoplasmosis and psychiatric disorders. There are reports of improvement of psychiatric symptoms with the absorption of retinochoroidal lesion due to toxoplasmosis [1] . In an interesting study the reactivity for toxoplasmin intradermal test, it was found to be highest in the manic depressive patients especially in the depressed patients, and the percentage of such patients increased with mental deterioration [2] . Symptom of toxoplasma chorioretinitis may masquerade as complaint of blurred vision a side effect of psychotropics like imipramine and trifluoperazine [3] . Possibilities of a relationship between toxoplasma infection and the occurrence of schizophrenia [4] and obsessive-compulsive disorder [5] have been suggested. It has been found that the individuals with firstepisode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to toxoplasma proteins, as compared with the control subjects [6] . We are reporting a patient whose depressive syndrome may be associated with the toxoplasmosis.
Case presentation
A 32 years old male presented with sad mood, anhedonia, suicidal ideas, impaired sleep, loss of appetite, multiple somatic complaints for 7 months was diagnosed to have depressive episode and was under treatment with antidepressants without much benefit. His somatic complaints were characterized by positional vertigo, tinnitus, weakness, feeling that the head is moving up and down and reeling of head. He had undergone detailed routine clinical examination in ophthalmology, otorhinolaryngology, endocrinology and neurosurgery departments for these complaints. Specific investigation like CT scan of brain, brainstem auditory evoked response did not show any abnormality. His HIV status was negative. However he was found positive on the serological test for the toxoplasma. He was treated with pyrimethamine and sulphadiazine. He was also prescribed carbamazepine 600 mg, clonazepam 4 mg and sertraline 100 mg per day. He came for regular follow-ups and after 6 months he was found to have recovered completely, and free from any evidence of toxoplasma infection.
Conclusion
The patient responded to the antidepressant therapy after he was treated for the toxoplasmosis. This case bringing to the fore the toxoplasma seropositivity and non-response to depression suggests a probable association between toxoplasmosis and depression. Though there has been strong indication that toxoplasmosis can be associated with various psychiatric disorders, we do agree that for a clearer association more accurate and rigorous proofs are required than those presented in this communiqué.
